Cargando…

The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies

SIMPLE SUMMARY: Through their regulatory effects on gene expression, histone acetyltransferases have been implicated in the normal physiological activities and genesis of cancer. Genetic aberrations of CREBBP/EP300 have been observed in various types of solid tumors and hematologic malignancies, mak...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yu, Wang, Zi, Li, Yanan, Peng, Hongling, Liu, Jing, Zhang, Ji, Xiao, Xiaojuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953837/ https://www.ncbi.nlm.nih.gov/pubmed/36831561 http://dx.doi.org/10.3390/cancers15041219

Ejemplares similares

Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors
por: Crawford, McKenna C., et al.
Publicado: (2023)

Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300
por: Williams, Lynn M., et al.
Publicado: (2020)

CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation
por: Garcia-Carpizo, Veronica, et al.
Publicado: (2018)

CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein–Taybi syndrome
por: Wincent, Josephine, et al.
Publicado: (2015)

CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas
por: Veazey, Kylee J., et al.
Publicado: (2020)

Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP
por: Qian, Maoxiang, et al.
Publicado: (2017)

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells
por: Bommi-Reddy, Archana, et al.
Publicado: (2022)

Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report
por: Al-Qattan, Mohammad M., et al.
Publicado: (2019)

Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma
por: Nie, Man, et al.
Publicado: (2021)

High affinity between CREBBP/p300 and NCOA evolved in vertebrates
por: Karlsson, Elin, et al.
Publicado: (2020)

Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function
por: Kumar, Manish, et al.
Publicado: (2021)

Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies
por: Wang, Zi, et al.
Publicado: (2021)

Directional divergence of Ep300 duplicates in teleosts and its implications
por: Wang, Xianzong, et al.
Publicado: (2020)

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
por: Huang, Yao-Hui, et al.
Publicado: (2021)

Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
por: Zhao, Yan, et al.
Publicado: (2021)

Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors
por: Horton, Sarah J., et al.
Publicado: (2017)

The Research Advances of Aptamers in Hematologic Malignancies
por: Liao, Yongkang, et al.
Publicado: (2023)

The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice
por: Schoof, Melanie, et al.
Publicado: (2023)

Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis
por: Holmstrom, Sam R., et al.
Publicado: (2019)

SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
por: Andrades, Alvaro, et al.
Publicado: (2023)

A novel CREBBP mutation and its phenotype in a case of Rubinstein–Taybi syndrome
por: Wang, Qian, et al.
Publicado: (2022)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation
por: Luo, Mayao, et al.
Publicado: (2023)

Notch signaling: its roles and therapeutic potential in hematological malignancies
por: Gu, Yisu, et al.
Publicado: (2016)

Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients
por: Bentivegna, Angela, et al.
Publicado: (2006)

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
por: Pisapia, David J., et al.
Publicado: (2020)

CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
por: Zhao, Ailin, et al.
Publicado: (2023)

Therapeutic Benefits of Selenium in Hematological Malignancies
por: Ehudin, Melanie A., et al.
Publicado: (2022)

Therapeutic Advances in Immunotherapies for Hematological Malignancies
por: Nogami, Ayako, et al.
Publicado: (2022)

The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies
por: Wang, Haobing, et al.
Publicado: (2022)

CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia
por: Fluhr, Silvia, et al.
Publicado: (2016)

Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort
por: Abraham Daniel, Ann, et al.
Publicado: (2023)

EP300 Protects from Light-Induced Retinopathy in Zebrafish
por: Kawase, Reiko, et al.
Publicado: (2016)

Aspirin induces autophagy via inhibition of the acetyltransferase EP300
por: Castoldi, Francesca, et al.
Publicado: (2018)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
por: Yang, Lei, et al.
Publicado: (2023)

EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs
por: Rubio, Karla, et al.
Publicado: (2023)

Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy
por: Yang, Xiao-Jing, et al.
Publicado: (2019)

EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019)

Case report: A preterm infant with rubinstein-taybi syndrome and Marmorata telangiectatica harboring a frameshift mutation in the CREBBP gene
por: Yang, Yang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cfqan9ri0ms7k50kjqrbc2nr7r